Why are tumour blood vessels abnormal and why is it important to know?
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Tumour blood vessels differ from their normal counterparts for reasons that have received little attention. We report here that they are of at least six distinct types, we describe how each forms, and, looking forward, encourage the targeting of tumour vessel subsets that have lost their vascular endothelial growth factor-A (VEGF-A) dependency and so are likely unresponsive to anti-VEGF-A therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although many in vitro microvessel models have been developed, none of them can actually reproduce the architecture of capillaries seen in a tumor [217,218].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [217]
Experimental — accuracy not yet measuredIn the citing paper
“The vasculature of tumors is very different from the blood vessels that supply healthy tissues, especially in terms of heterogeneity, permeability, multidirectional blood flow, and unordered distribution throughout the tumor160.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · cited 1×
“Furthermore, recent successes with agents that block VEGF-A or its receptors have supported Folkman’s (1971) thesis that anti-angiogenesis can be a useful supplement to traditional tumour therapy.”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“As was noted more than 20 years ago, tumour angiogenesis shares many analogies with wound healing (Dvorak, 1986).”
BackgroundSelf-citationTransplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., et al. (2007) · Nature · doi:10.1038/nature05571 · Cited by 1,775 · cited 1×
“…of endothelial cells: non-dividing ‘tip’ cells at the leading edge that extend filopodia and sprouts in response to VEGF-A gradients and ‘stalk’ cells that follow behind, divide and exhibit reduced filopodia and sprouting because of signalling through the Notch/delta 4 axis (Hellstrom et al, 2007).”
BackgroundBergers, G., Song, S., Meyer-Morse, N., Bergsland, E., & Hanahan, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17929 · Cited by 1,370 · cited 1×
“…that anti-VEGF/VEGFR approaches have effectively treated mouse tumours at early stages of their development, but have proved to be less successful in treating established mouse tumours that contain large numbers of more mature, smooth muscle-cell-coated blood vessels (Bergers et al, 2003).”
BackgroundBergers, G., Song, S., Meyer-Morse, N., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317929 · Cited by 1,192
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
Jain, R. K., Duda, D. G., Clark, J. W., & Loeffler, J. S. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0403 · Cited by 1,039 · cited 2×
“Agents that neutralise VEGF (e.g., Avastin, VEGF-TRAP) or its receptors have provided proof of principle that anti-angiogenesis can be a useful adjunct to tumour therapy (Jain et al, 2006).”
BackgroundRuhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., & Shima, D. T. (2002) · Genes & Development · doi:10.1101/gad.242002 · Cited by 914 · cited 2×
“Mice engineered to express only VEGF-A120 develop to term but generate a capillary network with larger-sized vessels and fewer branch points (Ruhrberg et al, 2002).”
BackgroundLee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D., & Iruela-Arispe, M. L. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409115 · Cited by 703 · cited 2×
“Similar large, MV-like vessels can be generated by still smaller VEGF-As that result from matrix metalloprotease cleavage (Lee et al, 2005).”
BackgroundVasculogenic Mimicry and Tumor Angiogenesis
Folberg, R., Hendrix, M. J. C., & Maniotis, A. J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64739-6 · Cited by 684 · cited 1×
“…and DV result, respectively, from arteriogenesis and venogenesis. aIn addition, red blood-cell-filled spaces lined by tumour cells rather than by vascular endothelium have been described in some tumours, particularly ocular melanomas, and are referred to as ‘vascular mimicry’ (Folberg et al, 2000).”
Background
Cited by
Items 501–600 of 612
Jiang, L., Du, B., Wu, Y., Cai, T., Zhang, G., Zhu, Y., Ding, B., Xue, H., Wu, X., Lin, H., et al. (2026) · Ultrasonics · doi:10.1016/j.ultras.2026.108119 · Cited by 1
Cell Patterning to Mimic Tumor Anatomy
Brennan-Smith, M. C., & Nelson, C. M. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166013-00163 · Cited by 1
Perspective Chapter: Impact of Tumor Metabolism on Immune Cells in the Tumor Microenvironment
Kotha, A., Madu, C. O., & Lu, Y. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108830 · Cited by 2
Chen, X., Huang, W., Tannenbaum, A., & Deasy, J. O. (2024) · SPIE Medical Imaging: Image Processing · doi:10.1117/12.3005382 · Cited by 1
Nanomedicine’s Transformative Role in Advancing Cancer Treatment
Vengurlekar, J. R., Bhaware, B. B., Prasad, T., & Sarkar, J. (2024) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-72467-1_4 · Cited by 2
Modulating Factors in Cancer: Dietary Phosphorus
Brown, R. B., & Mielke, J. G. (2025) · Springer eBooks · doi:10.1007/978-3-031-32047-7_76-1 · Cited by 1
3D multiparametric ultrasound of spontaneous murine tumors for non-invasive tumor characterization
Guillaumin, J.-B., Nadjem, A., Vigouroux, L., Sibleyras, A., Tanter, M., Aubry, J., & Berthon, B. (2025) · Physics in Medicine and Biology · doi:10.1088/1361-6560/adc8f4 · Cited by 1
“One of them is angiogenesis, the generation of a new vascular structure by the tumor to support its constant need for energy (Nagy et al 2009).”
Intratumoral Manipulation of the Immune Microenvironment of Solid Tumors
Mao, L., Xu, K., Jin, T., Yan, W., & Fang, R. H. (2025) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00063 · Cited by 1
Budhy, T. I. (2016) · Dentika Dental Journal · doi:10.32734/dentika.v19i1.142 · Cited by 1
Zhang, Y., Wang, S., Wang, H., Yang, Y., & Gao, J. (2020) · ChemNanoMat · doi:10.1002/cnma.202000309 · Cited by 1
Cook's Hernia: Renal Tumor Parasitic Vessels Herniating into Right Inguinal Canal
Taylor, Z., Brimley, A., Meinzer, M., Cook, C. E. A., & Henderson, S. J. (2020) · Current Urology · doi:10.1159/000499243 · Cited by 1
Mulita, F., Benetatos, N., Maroulis, I. C., & Germanos, S. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-240056 · Cited by 1
Cancer, Transformation and Human Behavior
Adjiri, A. (2020) · Open Access Journal of Cancer & Oncology · doi:10.23880/oajco-16000153 · Cited by 1
Optical Monitoring of Cerebral Microcirculation
Rejmstad, P. (2017) · doi:10.3384/diss.diva-133781 · Cited by 1
“The tumor blood vessels often grow in a coiling shape [62].”
BackgroundThe role of the integrin β3 adhesome in angiogenesis
Atkinson, S. J. (2018) · UEA Digital Repository (University of East Anglia) · Cited by 1
Optical Sectioning of Live Mammal with Near-Infrared Light SheetPreprint
Wang, F., Wan, H., Yue, J., Zhang, M., Ma, Z., Sun, Q., Qu, L., Ma, H., Zhong, Y., Tian, Y., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/447433 · Cited by 2
Optical detection of fractal dimensions of MUC13 stained pancreatic tissues for cancer diagnosticsPreprint
Adhikari, P., Binu, A. P., Bhandari, S., Khan, S., Jaggi, M., Chauhan, S. C., & Pradhan, P. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1812.10883 · Cited by 1
On chip complex breast tumour microenvironment: application to research in nanomedicine
Blondé, J.-B. (2020) · doi:10.3990/1.9789036550598 · Cited by 1
AIE Nanoprobes for NIR‐II Fluorescence In Vivo Functional Bioimaging
Feng, Z., Yu, X., & Qian, J. (2022) · Wiley eBooks · doi:10.1002/9781119643098.ch55 · Cited by 1
Yang, C. J., Bromma, K., & Chithrani, D. B. (2021) · doi:10.32920/14639037.v1 · Cited by 1
New functional vessels form after spinal cord injury in zebrafishPreprint
Ribeiro, A., da Costa, M. R., de Sena-Tomás, C., Rodrigues, E. C., Quitéria, R., Maçarico, T., Santos, S. C. R., & Saúde, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.09.495446 · Cited by 1
“Tortuosity can be a result of high local VEGF-A levels or the type of VEGF-A isoforms expressed (Nagy et al., 2009) and is frequently associated with hyperpermeability (Hashizume et al., 2000).”
BackgroundMaraqah, H. H., Abu-Asab, M. S., Lee, H. S., & Aboud, O. (2023) · Research Square · doi:10.21203/rs.3.rs-2456733/v1 · Cited by 1
Microfluidic Modulation of Microvasculature in Microdissected TumorsPreprint
Nguyen, T. N. H., Horowitz, L. F., Nguyen, B., Lockhart, E. J., Zhu, S., Gujral, T. S., & Folch, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.26.615278 · Cited by 2
Tumor Angiogenesis May Be A Tragedy of the CommonsPreprint
Bhattacharya, R., Bukkuri, A., Gatenby, R. A., & Brown, J. S. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5441855 · Cited by 2
Clinical Exploitation of Hypoxia
Higgins, G. S., & Harris, A. L. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9167-5_15
Nanomedicinas: lo esencial es invisible...al microscopio óptico
Romero, E. L., & Morilla, M. J. (2013) · Americanae (AECID Library)
Rôle clé de la kinase eEF2K dans la survie cellulaire à la privation de nutriments
Leprivier, G., Rotblat, B., Delattre, O., & Sorensen, P. H. B. (2013) · médecine/sciences · doi:10.1051/medsci/20132911007
Normalizing Tumor Vasculature Using Sepiapterin to Increase Radiosensitivity
Bruno, N. (2015) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/ghv4-0n53
“In contrast tumor vessels are convoluted, chaotic, and irregular [2].”
BackgroundRole of Mechanosensitive TRP Channels in Abnormal Vasculature of Tumors
Cappelli, H. C., Thoppil, R. J., Adapala, R. K., Meszaros, J. G., Paruchuri, S. M., & Thodeti, C. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-29635-7_12
Chemoprevention and Angiogenesis
Rao, S., Pankove, R. A., Mi, J., Elsey, J., & Arbiser, J. L. (2017) · Springer eBooks · doi:10.1007/978-1-4471-7314-4_7
The Implication of Antiangiogenic Treatment of Malignancies on Human Metabolism
Obad, N., & Bjerkvig, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-31215-6_35-1
“…tumor vasculature, consisting of multiple vessel subtypes ranging from capillaries to big fenestrated sinusoids and glomeruloid vessel structures, causing an abnormal, reduced, or sluggish blood flow and increased vascular permeability and interstitial fluid pressure (Nagy et al. 2009).”
BackgroundZhang, Q., Li, M., Shen, J., Tang, L., & Ji, J. (2017) · International Journal of Cancer and Oncology · doi:10.15436/2377-0902.17.1341
Agarwal, S. (2017) · Cited by 3
Biocompatible Nanoparticles for Selective Drug Release at Cancer Cells
Karagöz, F., Dorresteijn, R., Müllen, K., & Klapper, M. (2017) · ACS symposium series · doi:10.1021/bk-2017-1271.ch010
Kerketta, R. (2017) · UNM’s Digital Repository (University of New Mexico)
Visible Vessels of Vocal Folds: Can they have a Diagnostic Role?
ÇİLİNGİR, H. İ. T., Karsligil, M. E., & Koçak, İ. (2018) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405614666180604083854
Targeted and nanoparticle therapies for lung diseases
Trivedi, R. (2014) · doi:10.25677/ehjq-jy57
Identifying vessel branching from fluid stresses on microscopic robots
Hogg, T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817463-0.00006-x
“For instance, the geometry of capillaries differs among organs [3] and between normal and tumor vasculature [22,34].”
BackgroundKorzystka, A. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham)
Drapaca, C. S., & Sivaloganathan, S. (2019) · Fields Institute monographs · doi:10.1007/978-1-4939-9810-4_5
Nersesyan, A. (2019) · doi:10.17760/d20328712
“Newly formed capillaries are abnormal, highly branched, exhibit non-unidirectional blood flow, are mostly incomplete and often characterized as “leaky”, giving tumor cells easy access to the circulation [3, 5] and giving rise to tumor metastasis.”
Glycans as Targets and Mediators of T-Cell Immunotherapy
Wellhausen, N., Aguilar, W., & Posey, A. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00035-3
Sonografische Lymphknotendiagnostik im Bereich der unteren Extremitäten
Weskott, H.-P. (2020) · Phlebologie · doi:10.1055/a-1247-5486
Zhu, J. (2020) · Spiral (Imperial College London) · doi:10.25560/84258 · Cited by 1
Gabbiani, G., & Serini, G. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.7250957.7519055
Application of Optical Analyses to Cancer Therapeutics and Diagnostics
Fisher, A. P. (2020) · Cronfa (Swansea University) · doi:10.23889/suthesis.59833
Targeted Drug Delivery of Nanoparticles
Tonbul, H., & Çapan, Y. (2022) · Materials horizons · doi:10.1007/978-981-16-7483-9_8
Li, C., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Research Square · doi:10.21203/rs.3.rs-142861/v1 · Cited by 1
Dvorak, H. F. (2014) · Springer eBooks · doi:10.1007/978-1-4614-6613-0_2-4
Self-citationDvorak, H. F. (2017) · Springer eBooks · doi:10.1007/978-1-4419-0717-2_2
Self-citationThe Implication of Anti-angiogenic Treatment of Malignancies on Human Metabolism
Obad, N., & Bjerkvig, R. (2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2_35
Designing Strategies to Improve the T Cell Mediated Immunotherapy of Mouse Tumours.
Ataera, H. (2009) · doi:10.26686/wgtn.16969756
“Tumours are characterised by abnormal vasculature (167, 168) and necrotic areas, particularly in the centre of the tumour, leading to poor penetration of immune cells (167, 377).”
BackgroundYang, C. J., Bromma, K., & Chithrani, D. B. (2021) · doi:10.32920/14639037
Tsokos, G. C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727394204.793570386
朱, 敏. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.127952
Benzene fused pyrimidine-based derivatives and their biological properties
Kelm, J. M., Aruri, H., Nyalapatla, P. R., & Gavande, N. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-443-18616-5.00005-3
Chakroborty, D., & Sarkar, C. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_93
Tisza, A., Klikovits, T., Török, S., Szeitz, B., Valkó, Z., Megyesfalvi, Z., Hoda, M. A., Hegedűs, B., Bonta, M., Nischkauer, W., et al. (2023) · doi:10.22541/au.167275573.37513553/v1
Vuhahula, E. A. M., Yahaya, J. J., Ngaiza, A. I., Morgan, E. D., & Abraham, Z. S. (2023) · The Egyptian Journal of Otolaryngology · doi:10.1186/s43163-023-00397-0
“Also, large tumors are more likely to pose treatment challenges including inability to be excised completely due to involvement of vital structures such as nerves and blood vessels [35].”
Backgroundการแสดงออกของซด�146�ในรอยโรคไลเคน�แพลนสและมะเรงชองปากในผปวยไทย�
ปริยะวาที, ส., ทองประสม, ก., & ภัทรธราธิป, เ. (2017) · doi:10.58837/chula.the.2017.660
Amiloride Reduces FN3K Expression to Restore Sunitinib Sensitivity in Renal Cell CarcinomaPreprint
Bai, Y., You, Y., Chen, D., Chen, Y., Yin, Z., Liao, S., You, B., Lu, D., Sun, Y., Wu, L., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4593222
Caffaro, L. A. M. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-24112023-165858
Korani, S. S., Sabeti, S., Rosen, D., Fazzio, R. T., Larson, N. B., Fatemi, M., & Alizad, A. (2024) · Research Square · doi:10.21203/rs.3.rs-3879688/v1
Bax, M., & Romanov, V. (2024) · Springer series in biophysics · doi:10.1007/978-3-031-45379-3_3
Expression and Role of the Adrenomedullin System in Melanoma
Benyahia, Z., Gaudy‐Marqueste, C., Berenguer‐Daizé, C., Chabane, N., Dussault, N., Cayol, M., Vellutini, C., Djemli, A., Nanni, I., Beaufils, N., et al. (2024) · Book Publisher International (a part of SCIENCEDOMAIN International) · doi:10.9734/bpi/mria/v2/8351e
Innovative Prediction of VEGF Levels and Prognosis in Gastric Cancer through PET/CT-Based RadiomicsPreprint
Feng, H., Zhou, K., Yuan, Q., Liu, Z., Zhang, T., Chen, H., Xu, B. P., Sun, Z., Han, Z., Liu, H., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4791971/v1
An Introduction to Cancer Cell Biology and Genetics
Vickers, E. (2024) · Wiley eBooks · doi:10.1002/9781119834090.ch1
Николаевна, Д. И., Bylinskaya, K. A., Plekhanov, A. A., Kostyuk, A. B., Kirillin, M., Perekatova, V. V., Khilov, A. V., Orlova, A., Polozova, A. V., Komarova, A. D., et al. (2024) · Journal of Biophotonics · doi:10.1002/jbio.202400339 · Cited by 1
“The tendency of perfused vascular density to decrease as tumors grow, leading to ischemia and ultimately necrosis, is a well-known phenomenon, reflecting the fast growth rate of cancer cellular mass [57].”
Ben-Ami, Y., Wood, B. D., Pitt‐Francis, J., Maini, P. K., & Byrne, H. M. (2024) · Multiscale Modeling and Simulation · doi:10.1137/24m1632425
Khosrotehrani, K., Hashemi, G., Li, H., Tan, S. X., Zhou, C., Dight, J., Li, K., Nguyen, Q. H., Roy, E., & Sormani, L. (2024) · Research Square · doi:10.21203/rs.3.rs-5457583/v1
Carra, S., Gaudenzi, G., Franceschetti, G., Collini, M., Sironi, L., Bouzin, M., Persani, L., Chirico, G. G., Vitale, G., & D’Alfonso, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413392
Key Structural Features of Microvascular Networks Leading to the Formation of Multiple Equilibria
Atkinson, G., Ben-Ami, Y., Maini, P. K., Pitt‐Francis, J., & Byrne, H. M. (2025) · Bulletin of Mathematical Biology · doi:10.1007/s11538-024-01404-y
Superovulation-induced changes in murine ovarian perifollicular angiogenesis
Mappa, G., Barbieri, N. G., Freer, C., Cummings, M., & Orsi, N. M. (2025) · Reproduction · doi:10.1530/rep-25-0087
Chaudhary, P. K., Larson, N. B., Alizad, A., & Fatemi, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-09745-x
Jiang, W., Chen, Y., Chiang, Y.-Y., Yu, C., Lin, H., Chen, J.-Y., Huang, G., Chiu, H., Chung, C.-Y., Hsieh, M., et al. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102862
Kassimo, B. A., Yahaya, J. J., Othieno, E., Livex, O. A., & Odida, M. (2025) · African Health Sciences · doi:10.4314/ahs.v25i2.18 · Cited by 1
Tumor-on-a-Chip: From Biomimetic Tumor-Immune Microenvironments to Therapeutic Insights
Çetin, Y. (2025) · Biochemistry · doi:10.5772/intechopen.1012047
Li, M., Fang, Z., Ji, Y., Yu, T., Li, Y., Cheng, W., Duan, Y., Wang, X., Feng, J., Zhang, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-26694-7
Behera, A., Lodha, S., Sa, N., Rout, S. S., Kalyankar, G. G., Panchal, N., & Sabnani, M. K. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898811747125010009
Epigenetic dysregulation of novel candidate genes in melanoma
Wang, H. (2013) · Discovery Research Portal (University of Dundee)
Cong, L., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Figshare · doi:10.6084/m9.figshare.14562708
Cong, L., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Figshare · doi:10.6084/m9.figshare.14562711
Pérez-Miles, F., Gabriel, R., Miglio, L., Bonaldo, A., Gallon, R., Jiménez, J. J., & Bertani, R. (2008) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.184594
Clinical Prognostic Significance of LRG1 in Metastatic Breast Cancer
Muendlein, A., Brandtner, E. M., Heinzle, C. F., Geiger, K. D., Leiherer, A., Benda-Beck, M., Reimann, P., Dechow, T. N., & Decker, T. (2026) · Oncology Research and Treatment · doi:10.1159/000550608
“The resulting abnormal vasculature accelerates tumor progression and metastasis, promotes EMT, suppresses effective anti-tumor immune responses, and impairs the delivery and efficacy of systemic therapies and immunotherapies [15–17].”
Rai, Z. L., Holroyd, N., Magbagbeola, M., Doganay, E., Doyle, K., Caselton, L., Stilli, A., Stoyanov, D. V., Walker‐Samuel, S., & Davidson, B. R. (2026) · NMR in Biomedicine · doi:10.1002/nbm.70236
“Vessel tortuosity, for example, is a hallmark of many cancer types [32] among other conditions [33], while liver pathologies such as cirrhosis are known to cause changes in vessel diameter [34].”
Ferraro, R., Guido, S., & Caserta, S. (2026) · Physics of Fluids · doi:10.1063/5.0319239
Etude et inhibition de l'activation endothéliale au cours de l'angiogenèse
Cossutta, M. (2017) · theses.fr (ABES) · doi:10.70675/b2ab1c80zb5caz47c4za53bz83c66b494fda · Cited by 1
Netrin-1 in extracellular vesicles : a new secretory pathway
Fiore, S. (2019) · theses.fr (ABES) · doi:10.70675/d67eb9cdz25f4z4d1czbf7czf70e76f70396
Development and application of new strategies for data fusion of hyperspectral images
Gómez‐Sánchez, A. (2024) · theses.fr (ABES) · doi:10.70675/60658e0az5e82z4b86z9463z465911c9ee93
Paseta, O., García‐Aznar, J. M., & Gómez‐Benito, M. J. (2026) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2026.109430
Progressive insights into nanomaterials for cancer starvation therapy
Shi, J., Cui, J., Sun, X., Sun, J., He, Z., Luo, C., & Zhang, S. (2026) · Science China Materials · doi:10.1007/s40843-025-3988-6
“Tumor blood vessels, with rapid proliferation, abnormal structure, and lack of peri-cytes/basement membrane compared to normal vessels [104], are more fragile and immature, making them more susceptible to vascular-damaging agents.”
Angiogenic Doping: Plausible Yet Difficult to Detect
Lehto, S., Sima, S., Künnapuu, J., Iljukov, S., & Jeltsch, M. (2026) · Sports Medicine · doi:10.1007/s40279-026-02447-y
“VEGF-A expression by this mouse ovarian tumor resulted in higher capillary density, but did not produce a hierarchical network optimized for oxygen delivery (see also [24, 25]); image CC-licensed from [165].”
Wei, W., Lu, W., Zhou, W., Zhang, D., Xu, X., Zhou, J., Gao, Y., Duan, Y., & Zhang, C. (2026) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s596312
“Mean tortuosity was paradoxically higher in benign lesions, which may reflect the composition of the benign BI-RADS 4–5 subgroup, including biologically active lesions that increased average tortuosity without exhibiting extreme vascular distortion.”
Koenig, F. R. M., Görg, C., Prosch, H., Vetchy, V., Hohensteiner, A., Gantner, N. A., Kifjak, D., Lindenlaub, F., Funovics, P. T., Nöebauer-Huhmann, I.-M., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16111706
“Rapid washout may reflect extensive pathological shunting and can be interpreted as a surrogate marker of aberrant angiogenesis, thereby constituting a potential warning sign of underlying vascular remodeling [23,24].”
Ultrasound-responsive drug nanocarriers in oncology: key determinants of therapeutic performance
Reete, F., Wu, Z., & Thakur, S. S. (2026) · Journal of Liposome Research · doi:10.1080/08982104.2026.2681623
Metadata
- Authors
- Nagy, J. A., Chang, S.-H., Dvorak, A. M., & Dvorak, H. F.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Dvorak, H F
- ORCID
- Nagy, J A
- Venue
- British Journal of Cancer
- Published
- 2009-02-24
- Volume
- 100
- Issue
- 6
- Pages
- 865-869
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC2661770
- OpenAlex
- W2063556542
- Cited by
- 611
- References
- 38
- Citations by year
- 2026: 30 · 2025: 39 · 2024: 62 · 2023: 47 · 2022: 50 · 2021: 53 · 2020: 61 · 2019: 47 · 2018: 51 · 2017: 48 · 2016: 22 · 2015: 16 · 2014: 12 · 2013: 18 · 2012: 20
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Foundation for Cancer Research
- National Heart, Lung, and Blood Institute (R01HL064402, HL-64402)
- National Cancer Institute (P01 CA 92644, P01CA092644)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor vasculature, VEGF-A, anti-VEGF therapy, tumor angiogenesis, anti-angiogenic therapy resistance
- MeSH terms
- Animals, Blood Vessels, Capillaries, Humans, Neoplasms, Neovascularization, Pathologic, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.